Out-licensing

Messenger Biopharma will not develop its own mRNA products.

We are eager to out-license our Aegis biotechnology to pharmaceutical and biotech companies for vaccine and gene therapy products development.

Last news

article

Réseau Entreprendre Auvergne has rewarded twenty projects of creation or…

posted June 20, 2016

“Réseau Entreprendre Auvergne has rewarded ...Read More